No title
Background: Ulcerative colitis (UC) is a chronic inflammatory disease of the colon with unclear pathogenesis. A dysbiotic intestinal microbiota is regarded as a key component in the disease process and there has been significant interest in developing new treatments which target the microbiota. Aim: To give an overview of the studies to date investigating prebiotics and synbiotics for the treatmen
